Alterity Therapeutics (ATHE) Net Margin (2016 - 2020)

Alterity Therapeutics' Net Margin history runs 5 years deep, the most recent figure standing at 0.86% for Q4 2020.

• In Q4 2020, Net Margin rose 21900.0% year-over-year to 0.86%; the TTM figure through Dec 2021 stood at 77.93% (up 7709.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
• Net Margin was 0.86% for Q4 2020 at Alterity Therapeutics, up from 218.14% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 0.86% in Q4 2020 to a low of 308.48% in Q4 2017.
• Historically, Net Margin has averaged 139.0% across 5 years, with a median of 95.29% in 2016.
• The sharpest annual moves came in 2017 and 2018: Net Margin tumbled 21319 bps in 2017, then surged 23453 bps in 2018.
• A 5-year view of Net Margin shows it stood at 95.29% in 2016, then sank by 224 bps to 308.48% in 2017, then soared by 76 bps to 73.95% in 2018, then plunged by 195 bps to 218.14% in 2019, then soared by 100 bps to 0.86% in 2020.
• The last three Net Margin figures came in at 0.86% (Q4 2020), 218.14% (Q4 2019), and 73.95% (Q4 2018), per Business Quant data.